Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-047884
Filing Date
2023-04-20
Accepted
2023-04-20 17:20:31
Documents
5
Period of Report
2023-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm232159d3_def14a.htm DEF 14A 403919
2 GRAPHIC tm232159d1_pre14aimg01.jpg GRAPHIC 13651
3 GRAPHIC tm232159d1_pre14aimg02.jpg GRAPHIC 4720
4 GRAPHIC tm232159d1_pre14aimg04.jpg GRAPHIC 130039
5 GRAPHIC tm232159d1_pre14aimg03.jpg GRAPHIC 138616
  Complete submission text file 0001104659-23-047884.txt   800799
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39580 | Film No.: 23833984
SIC: 2834 Pharmaceutical Preparations